RecruitingPhase 3NCT06361537
Rare condition
Hereditary angioedema with normal C1Inh
4
studies recruiting now
as of 7 Sept 2026
40
studies registered in total
as of 7 Sept 2026
26
countries with a recruiting site
as of 7 Sept 2026
4 Mar 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 3NCT07266805
Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant IR Capsule for On-Demand Treatment of Angioedema Attacks in Adults With Acquired Angioedema Due to C1 Inhibitor Deficiency
RecruitingNCT07448181
Real-life Ecological Momentary Assessment of Lived Burden in Hereditary AngioEdema
RecruitingPhase 1 / Phase 2NCT07046806
Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema Patients
Showing the 4 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
Search all Hereditary angioedema with normal C1Inh studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Hereditary angioedema with normal C1Inh study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Hereditary angioedema with normal C1Inh
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).